Literature DB >> 16635495

Cognitive changes in early MS: a call for a common framework.

A Achiron1, Y Barak.   

Abstract

Cognitive dysfunction is among the main symptoms of multiple sclerosis (MS) and adversely affects patients' quality of life. The occurrence of cognitive impairment early in the disease process raises crucial issues related to definition of the impairment and its magnitude as well as to the tools applied to the assessment. To date there is little evidence concerning the reliability and validity of cognitive measures in early MS and their predictive long-term role. As MS is a complex disease, multidimensional approaches should be further developed and validated to study the cognitive sphere in the early stages of the disease. Considering that none of the available tests performed in isolation is able to provide a complete picture of the cognitive impairment in early MS, this calls for the definition of phase duration, impairment and tools appropriate for use by clinicians and researches. The present review proposes a framework aimed to help neurologists in approaching cognitive impairment in early MS and stimulate discussions and evaluations of the suggested recommendations.

Entities:  

Mesh:

Year:  2006        PMID: 16635495     DOI: 10.1016/j.jns.2005.05.019

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

1.  Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.

Authors:  R S Prakash; E M Snook; J M Lewis; R W Motl; A F Kramer
Journal:  Mult Scler       Date:  2008-08-13       Impact factor: 6.312

2.  The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis.

Authors:  T A M Siepman; A C J W Janssens; I de Koning; C H Polman; J B Boringa; R Q Hintzen
Journal:  J Neurol       Date:  2008-05-20       Impact factor: 4.849

3.  Cognitive function and quality of life in multiple sclerosis patients: a cross-sectional study.

Authors:  Karine Baumstarck-Barrau; Marie-Claude Simeoni; Françoise Reuter; Irina Klemina; Valérie Aghababian; Jean Pelletier; Pascal Auquier
Journal:  BMC Neurol       Date:  2011-02-02       Impact factor: 2.474

4.  Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study.

Authors:  Karine Baumstarck; Jean Pelletier; Valérie Aghababian; Françoise Reuter; Irina Klemina; Julie Berbis; Anderson Loundou; Pascal Auquier
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

5.  What is the relevance of quality of life assessment for patients with attention impairment?

Authors:  Karine Baumstarck; Mohamed Boucekine; Irina Klemina; Françoise Reuter; Valérie Aghababian; Anderson Loundou; Jean Pelletier; Pascal Auquier
Journal:  Health Qual Life Outcomes       Date:  2013-04-25       Impact factor: 3.186

6.  Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.

Authors:  Anat Achiron; Joab Chapman; David Magalashvili; Mark Dolev; Mor Lavie; Eran Bercovich; Michael Polliack; Glen M Doniger; Yael Stern; Olga Khilkevich; Shay Menascu; Gil Hararai; Micharel Gurevich; Yoram Barak
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

7.  Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices.

Authors:  Karine Baumstarck; Mohamed Boucekine; Laurent Boyer; Valérie Aghababian; Nathalie Parola; Françoise Reuter; Anderson Loundou; Christophe Lançon; Jean Pelletier; Pascal Auquier
Journal:  BMC Neurol       Date:  2014-04-08       Impact factor: 2.474

8.  Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study.

Authors:  J H Faiss; D Dähne; K Baum; R Deppe; F Hoffmann; W Köhler; A Kunkel; A Lux; M Matzke; I K Penner; M Sailer; U K Zettl
Journal:  BMJ Open       Date:  2014-04-10       Impact factor: 2.692

Review 9.  Neurobehavioral burden of multiple sclerosis with nanotheranostics.

Authors:  Bhasker Sriramoju; Rupinder K Kanwar; Jagat R Kanwar
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-15       Impact factor: 2.570

Review 10.  Cognitive impairment in clinically isolated syndrome: A systematic review.

Authors:  Carolina Fiorin Anhoque; Simone Cristina Aires Domingues; Antônio Lúcio Teixeira; Renan Barros Domingues
Journal:  Dement Neuropsychol       Date:  2010 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.